Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venus Medicine Research Centre (VMRC) is the research and development arm of Venus Remedies Limited, a global pharmaceutical company headquartered in India. The center focuses on developing innovative solutions for antimicrobial resistance (AMR), oncology, and neurology, with a particular emphasis on superbug-tackling antibiotics. VMRC is known for its proprietary technologies like Targeted Antigen Chelation (TAC) and has successfully commercialized several fixed-dose combinations and novel drug delivery systems. The facility is GLP-certified and has received numerous international patents for its research in anti-infectives and specialized therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venus Research Center.